Comparative effectiveness

Showing 9 of 0 results

• The BEV1L study: do real-world outcomes associated with the addition of bevacizumab to first-line chemotherapy in patients with ovarian cancer reinforce clinical trial findings?

  Cancer

  • Real-world evidence
  • Treatment patterns
  • Comparative effectiveness
  • Ovarian cancer
• Using regression discontinuity in time design for real-world comparative effectiveness: A case study for the second-line use of pembrolizumab in advanced non-small cell lung cancer

  ISPOR 2025

  • Publication summary
  • Publications
  • Comparative effectiveness
  • Non-small cell lung cancer
• Comparative overall survival of CDK4/6 inhibitors plus an aromatase inhibitor in HR+/HER2− metastatic breast cancer in the US real-world setting

  ESMO Open

  • Real-world evidence
  • Publication summary
  • Publications
  • Comparative effectiveness
  • Metastatic breast cancer
• Effectiveness of PARP inhibitor maintenance therapy in advanced ovarian cancer by BRCA1/2 and HRD signature in real-world practice

  ASCO Annual Meeting

  • Publication summary
  • Publications
  • Comparative effectiveness
  • Drug discovery
  • Ovarian cancer
• Emulating randomized controlled trials with hybrid control arms in oncology: a case study

  Clinical Pharmacology & Therapeutics

  • Real-world evidence
  • Publication summary
  • Publications
  • Methodology
  • Comparative effectiveness
  • Non-small cell lung cancer
• Augmenting control arms with real-world data for cancer trials: Hybrid control arm methods and considerations

  Contemporary Clinical Trials Communications

  • Real-world evidence
  • Publication summary
  • Publications
  • Methodology
  • Comparative effectiveness
  • Metastatic breast cancer
• Generating real-world external comparators (rwECs) for randomized clinical trials (RCTs) in metastatic breast cancer (mBC) using electronic health records (EHRs)

  SABCS

  • Publications
  • Methodology
  • Comparative effectiveness
  • Metastatic breast cancer
• Exploring the potential for EHR-derived real-world data to reduce uncertainty in HTA decision-making: a case study of long-term survival outcomes

  EU ISPOR

  • Publications
  • Comparative effectiveness
  • Non-small cell lung cancer
  • HTA and market access
• Real-world overall survival using oncology electronic health record data: Friends of Cancer Research Pilot

  Clinical Pharmacology & Therapeutics

  • Publications
  • Methodology
  • Comparative effectiveness
  • Non-small cell lung cancer